🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yonghong Chen

National Laboratory of the Rockies

ORCID: 0000-0001-9552-1308

Also affiliated with Chongqing University, Yunnan University, Nantong University, Zhejiang Yongning Pharma (China), University of Tennessee at Knoxville

EngineeringMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “Development of a clinical prediction model for sensitivity to combination therapy of Bcl-2 inhibitors and hypomethylating agents in elderly/unfit patients with acute myeloid leukemia”.

Development of a clinical prediction model for sensitivity to combination therapy of Bcl-2 inhibitors and hypomethylating agents in elderly/unfit patients with acute myeloid leukemia

Discover Oncology(2025)10.1007/s12672-025-02612-1
N/A
0.104DataRank · unranked
1 citations

Chunhong Li, Yonghong Chen, Fang Xie, Jinsong Yan, Yufeng Du

APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.14.552850
N/A
0DataRank · unranked
7 citations

Megan S. Keiser, Jonah C Meltzer, Dustin P. Fykstra, Steven E. Dierksmeier, Alexandra Melloni +9 more

APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease

Molecular Therapy(2024)10.1016/j.ymthe.2024.03.024
N/A
0DataRank · unranked
70 citations

Megan S. Keiser, Jonah C Meltzer, Dustin P. Fykstra, Steven E. Dierksmeier, Soroush Hajizadeh +14 more

AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALS

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.31.578314
N/A
0DataRank · unranked
6 citations

Ashley B. Robbins, Alicia R. Smith, Katherine R. Whiteman, G. Bosch, Yonghong Chen +7 more

AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice

Nature Communications(2025)10.1038/s41467-025-60497-8
N/A
0DataRank · unranked
8 citations

Ashley B. Robbins, Katherine R. Whiteman, Alicia R. Smith, Guillem Chillon, Yonghong Chen +10 more